A detailed history of Ever Source Wealth Advisors, LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 252 shares of ORGO stock, worth $690. This represents 0.0% of its overall portfolio holdings.

Number of Shares
252
Holding current value
$690
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$2.89 - $6.21 $728 - $1,564
252 New
252 $1,000
Q1 2023

May 11, 2023

SELL
$1.89 - $2.93 $3,041 - $4,714
-1,609 Reduced 64.28%
894 $1,000
Q4 2022

Feb 09, 2023

BUY
$2.48 - $3.43 $6,207 - $8,585
2,503 New
2,503 $6,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $359M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.